Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc. (OBIO) is a healthcare-focused special purpose acquisition company that filed a quarterly report on Form 10-Q with the SEC on August 16, 2021, under accession number 0001213900-21-043010. The SPAC was organized to pursue a business combination in the medical device and bioelectronic medicine space, targeting innovations at the intersection of cardiovascular treatment and implantable device technology. Orchestra BioMed Holdings completed its SPAC IPO in 2021 and was actively engaged in evaluating target companies within the health sciences sector at the time of this filing. For comprehensive data on OBIO, including deal timelines, financial filings, and comparable SPAC transactions, sign up for full access at SpacDesk.